TSXV/NAV (TSXV/NAV)

TSX Venture Exchange: TSXV/NAV · CAD

CA$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	285.3K
Net income (ttm)	-68.8K
EPS (ttm)	-CA$0.00
Shares out	57.1M
Volume	0
Beta	2.14

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -68.8K
EPS (ttm): -CA$0.00
Market cap: 285.3K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/NAV indicators

Market & fundamental data

Available fields

107

Groups with data

Currency

CAD

Showing 107 of 107 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2027-01-29
Enterprise value	CAD 395,757
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	September
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA63942R1091
Last earnings date	2026-01-29
Last refreshed	2026-10-30
Market cap	CAD 285,348
Next earnings date	2027-01-29
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	tsxv/NAV
Website	https://navcopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-24.12%
FCF / EV yield	-6.67%
FCF yield	-9.25%
Industry forward P/E	34.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-741.21%
ROCE	4.28%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	CAD -41,354
EPS	CAD -0.00
FCF per share	CAD -0.00
Financing cash flow	CAD 20,000
Free cash flow	CAD -26,393
Net borrowing	CAD 20,000
Net cash flow	CAD -6,393
Net income	CAD -68,839
Operating income	CAD -41,354

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD -0.02
Interest coverage	-3.56
Long-term assets	CAD 0
Long-term liabilities	CAD 0
Net cash (debt)	CAD -110,410
Net cash / market cap	-38.69%
Piotroski F-Score	1
Shareholders' equity	CAD -965,378
Tangible book value	CAD -965,378
Tangible book value per share	CAD -0.02
Total assets	CAD 290
Total cash	CAD 290
Total debt	CAD 110,700
Total liabilities	CAD 965,668
WACC	13.87%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 290
Current liabilities	CAD 965,668
Current ratio	0
Net working capital	CAD -854,968
Quick ratio	0
Working capital	CAD -965,378

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.02%
Shareholder yield	0.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.01
1D price change	0%
20-day SMA	CAD 0.01
200-day SMA	CAD 0.02
3Y price change	-85.71%
3Y return CAGR	-47.72%
3Y total return	-85.71%
50-day SMA	CAD 0.01
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.01
52-week high date	2026-08-18
52-week low	CAD 0.01
52-week low date	2026-10-28
All-time high	CAD 0.45
All-time high date	2023-04-18
All-time low	CAD 0.01
All-time low date	2025-02-28
Average true range (ATR)	CAD 0.00
Average volume	16.7K
Beta (1Y)	-1.69
Beta (2Y)	-1.31
Beta (5Y)	2.14
Change from 52-week high	-50%
Change from 52-week low	0%
Change from all-time high	-98.89%
Change from all-time low	0%
Monthly RSI	31.72
Previous close	CAD 0.01
Price vs 150-day SMA	-43.18%
Price vs 20-day SMA	-9.09%
Price vs 200-day SMA	-67.95%
Price vs 50-day SMA	-25.37%
Relative volume	0.06
RSI	44.54
Sharpe ratio	1.7
Sortino ratio	3.42
Volume	0
Weekly RSI	41.11
YTD price change	-50%
YTD total return	-50%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	51.8M
Shares change (QoQ)	0%
Shares change (YoY)	-0.02%
Shares held by insiders	9.2%
Shares outstanding	57.1M

Deeper analysis on TSXV/NAV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/NAV report

Is a complete TSXV/NAV research report available?

No complete published report is available for tsxv/NAV (TSXV/NAV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/NAV (TSXV/NAV)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/NAV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/NAV indicators

Profile and market data

Valuation

Profitability

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/NAV

Frequently asked questions